Genscript Biotech Corporation (GNNSF)
OTCMKTS · Delayed Price · Currency is USD
2.190
0.00 (0.00%)
Aug 14, 2025, 8:00 PM EDT
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of $4.94 billion as of August 15, 2025. Its market cap has increased by 38.53% in one year.
Market Cap
4.94B
Enterprise Value
5.04B
Revenue
594.49M
Ranking
n/a
PE Ratio
1.67
Stock Price
$2.19
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 272.50M to 4.94B, an increase of 1,712.66%. That is a compound annual growth rate of 35.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 4.94B | 81.87% |
| Dec 31, 2024 | 2.72B | -49.68% |
| Dec 29, 2023 | 5.40B | -19.93% |
| Dec 30, 2022 | 6.74B | -27.50% |
| Dec 31, 2021 | 9.30B | 227.16% |
| Dec 31, 2020 | 2.84B | -33.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 567.91M |
| Elite Pharmaceuticals | 567.29M |
| American Oncology Network | 389.51M |
| Northwest Biotherapeutics | 362.70M |
| CytoDyn | 336.73M |